| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.0B | $3.1B | $2.1B | $1.0B | $0.6B | $0.9B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $1.7B | $1.1B | $1.0B | $0.4B | $-0.8B | $0.1B | $0.3B |
| Net Income | $0.9B | $1.0B | $0.5B | $0.5B | $0.1B | $-0.7B | $0.0B | $0.2B |
| EPS (Basic) | $1.31 | $1.54 | $1.36 | $1.80 | $0.49 | $-2.46 | $0.06 | $0.76 |
| EPS (Diluted) | $1.28 | $1.45 | $1.24 | $1.61 | $0.46 | $-2.46 | $0.06 | $0.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.9B | $16.9B | $15.0B | $8.5B | $3.8B | $3.8B | $4.7B | $4.3B |
| Current Assets | $1.3B | $1.1B | $0.7B | $0.5B | $0.1B | $0.1B | $0.1B | $0.1B |
| Cash & Equivalents | $0.2B | $0.5B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $6.4B | $6.4B | $5.7B | $2.8B | $1.1B | $1.2B | $1.4B | $1.0B |
| Current Liabilities | $1.7B | $1.3B | $1.2B | $0.6B | $0.2B | $0.1B | $0.3B | $0.2B |
| Stockholders' Equity | $10.3B | $9.1B | $6.3B | $2.9B | $2.8B | $2.6B | $3.3B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.6B | $3.4B | $2.2B | $1.4B | $0.5B | $0.2B | $0.6B | $0.7B |
| Investing Cash Flow | $-2.9B | $-3.1B | $-1.6B | $-1.2B | $-0.2B | $-0.3B | $-0.9B | $-1.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $0.1B | $-0.6B | $-0.1B | $-0.3B | $0.1B | $0.4B | $0.3B |